surgery partners inc - SGRY

SGRY

Close Chg Chg %
14.12 0.00 0.00%

Closed Market

14.12

0.00 (0.00%)

Volume: 3.28M

Last Updated:

Sep 10, 2026, 4:00 PM EDT

Company Overview: surgery partners inc - SGRY

SGRY Key Data

Open

$14.09

Day Range

13.72 - 14.18

52 Week Range

11.41 - 23.44

Market Cap

$1.83B

Shares Outstanding

130.92M

Public Float

78.00M

Beta

1.92

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.69

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.61M

 

SGRY Performance

1 Week
 
-0.98%
 
1 Month
 
-6.37%
 
3 Months
 
-7.77%
 
1 Year
 
-35.44%
 
5 Years
 
-70.66%
 

SGRY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About surgery partners inc - SGRY

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the Surgical Facility segment. The Surgical Facility segment includes the operation of ambulatory surgery centers, surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. The company was founded in 2004 and is headquartered in Brentwood, TN.

SGRY At a Glance

Surgery Partners, Inc.
340 Seven Springs Way
Brentwood, Tennessee 37027
Phone 1-615-234-5900 Revenue 3.31B
Industry Hospital/Nursing Management Net Income -77,900,000.00
Sector Health Services 2025 Sales Growth 6.242%
Fiscal Year-end 12 / 2026 Employees 16,000
View SEC Filings

SGRY Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.594
Price to Book Ratio 1.166
Price to Cash Flow Ratio 7.17
Enterprise Value to EBITDA 11.689
Enterprise Value to Sales 2.286
Total Debt to Enterprise Value 0.532

SGRY Efficiency

Revenue/Employee 206,793.75
Income Per Employee -4,868.75
Receivables Turnover 5.494
Total Asset Turnover 0.407

SGRY Liquidity

Current Ratio 1.87
Quick Ratio 1.713
Cash Ratio 0.39

SGRY Profitability

Gross Margin 17.802
Operating Margin 14.229
Pretax Margin 3.533
Net Margin -2.354
Return on Assets -0.959
Return on Equity -4.448
Return on Total Capital -1.358
Return on Invested Capital -1.423

SGRY Capital Structure

Total Debt to Total Equity 234.97
Total Debt to Total Capital 70.147
Total Debt to Total Assets 48.833
Long-Term Debt to Equity 226.68
Long-Term Debt to Total Capital 67.672
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Surgery Partners Inc - SGRY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.54B 2.74B 3.11B 3.31B
Sales Growth
+14.12% +8.03% +13.52% +6.24%
Cost of Goods Sold (COGS) incl D&A
2.08B 2.21B 2.52B 2.72B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
149.60M 118.10M 153.50M 176.30M
Depreciation
143.20M 110.50M 144.80M 170.20M
Amortization of Intangibles
6.40M 7.60M 8.70M 6.10M
COGS Growth
+13.46% +6.48% +13.88% +7.87%
Gross Income
460.10M 529.40M 593.00M 589.00M
Gross Income Growth
+17.19% +15.06% +12.01% -0.67%
Gross Profit Margin
+18.12% +19.30% +19.04% +17.80%
2022 2023 2024 2025 5-year trend
SG&A Expense
102.20M 120.90M 138.70M 118.20M
Research & Development
- - - -
-
Other SG&A
102.20M 120.90M 138.70M 118.20M
SGA Growth
-1.73% +18.30% +14.72% -14.78%
Other Operating Expense
- - - -
-
Unusual Expense
31.10M 87.30M 104.40M 82.50M
EBIT after Unusual Expense
326.80M 321.20M 349.90M 388.30M
Non Operating Income/Expense
8.10M 41.50M 55.90M 7.90M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
12.50M 14.20M 19.50M 22.90M
Interest Expense
224.60M 227.70M 258.70M 279.30M
Interest Expense Growth
+14.42% +1.38% +13.61% +7.96%
Gross Interest Expense
224.60M 227.70M 258.70M 279.30M
Interest Capitalized
- - - -
-
Pretax Income
110.30M 135.00M 147.10M 116.90M
Pretax Income Growth
+35.84% +22.39% +8.96% -20.53%
Pretax Margin
+4.34% +4.92% +4.72% +3.53%
Income Tax
23.30M (300.00K) 134.60M 18.00M
Income Tax - Current - Domestic
1.50M 1.40M 3.10M 1.10M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
21.80M (1.70M) 131.50M 16.90M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
12.50M 14.20M 19.50M 22.90M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
87.00M 135.30M 12.50M 98.90M
Minority Interest Expense
141.60M 147.20M 180.60M 176.80M
Net Income
(54.60M) (11.90M) (168.10M) (77.90M)
Net Income Growth
+32.76% +78.21% -1,312.61% +53.66%
Net Margin Growth
-2.15% -0.43% -5.40% -2.35%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(54.60M) (11.90M) (168.10M) (77.90M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(54.60M) (11.90M) (168.10M) (77.90M)
EPS (Basic)
-0.5938 -0.0947 -1.3328 -0.6124
EPS (Basic) Growth
+47.03% +84.05% -1,307.39% +54.05%
Basic Shares Outstanding
91.95M 125.61M 126.12M 127.21M
EPS (Diluted)
-0.5938 -0.0947 -1.3328 -0.6124
EPS (Diluted) Growth
+47.03% +84.05% -1,307.39% +54.05%
Diluted Shares Outstanding
91.95M 125.61M 126.12M 127.21M
EBITDA
507.50M 526.60M 607.80M 647.10M
EBITDA Growth
+18.99% +3.76% +15.42% +6.47%
EBITDA Margin
+19.99% +19.20% +19.52% +19.56%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 18.636
Number of Ratings 12 Current Quarters Estimate 0.111
FY Report Date 09 / 2026 Current Year's Estimate 0.45
Last Quarter’s Earnings 0.10 Median PE on CY Estimate N/A
Year Ago Earnings 0.47 Next Fiscal Year Estimate 0.542
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 11 12 11 12
Mean Estimate 0.11 0.29 0.45 0.54
High Estimates 0.17 0.40 0.58 0.92
Low Estimate 0.06 0.20 0.29 0.18
Coefficient of Variance 32.07 21.23 19.41 39.57

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 9 9
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Surgery Partners Inc - SGRY

Date Name Shares Transaction Value
Mar 17, 2026 Jennifer B. Baldock Chief Admin & Dev Officer 326,474 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $13.17 per share 4,299,662.58

Surgery Partners Inc in the News